Centene ROE 2011-2025 | CNC
Current and historical return on equity (ROE) values for Centene (CNC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Centene ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-5.29B | $21.03B | -20.54% |
| 2025-06-30 | $2.05B | $27.49B | 7.51% |
| 2025-03-31 | $3.45B | $28.01B | 12.63% |
| 2024-12-31 | $3.31B | $26.50B | 12.20% |
| 2024-09-30 | $3.07B | $27.40B | 11.38% |
| 2024-06-30 | $2.82B | $27.44B | 10.67% |
| 2024-03-31 | $2.74B | $27.05B | 10.50% |
| 2023-12-31 | $2.70B | $25.94B | 10.57% |
| 2023-09-30 | $2.44B | $25.40B | 9.73% |
| 2023-06-30 | $2.71B | $25.77B | 10.78% |
| 2023-03-31 | $1.48B | $25.17B | 5.86% |
| 2022-12-31 | $1.20B | $24.18B | 4.65% |
| 2022-09-30 | $2.01B | $25.53B | 7.58% |
| 2022-06-30 | $1.86B | $26.43B | 6.94% |
| 2022-03-31 | $1.50B | $27.31B | 5.60% |
| 2021-12-31 | $1.35B | $26.94B | 5.08% |
| 2021-09-30 | $0.74B | $26.59B | 2.80% |
| 2021-06-30 | $0.72B | $26.05B | 2.76% |
| 2021-03-31 | $2.46B | $26.46B | 9.52% |
| 2020-12-31 | $1.81B | $25.89B | 7.19% |
| 2020-09-30 | $2.03B | $25.84B | 9.29% |
| 2020-06-30 | $1.56B | $25.17B | 8.42% |
| 2020-03-31 | $0.85B | $23.66B | 5.54% |
| 2019-12-31 | $1.32B | $12.66B | 10.80% |
| 2019-09-30 | $1.35B | $12.41B | 11.44% |
| 2019-06-30 | $1.28B | $12.25B | 11.19% |
| 2019-03-31 | $1.08B | $11.63B | 9.82% |
| 2018-12-31 | $0.90B | $11.01B | 8.99% |
| 2018-09-30 | $0.89B | $10.75B | 9.91% |
| 2018-06-30 | $1.08B | $10.70B | 13.52% |
| 2018-03-31 | $1.03B | $7.58B | 14.97% |
| 2017-12-31 | $0.83B | $6.86B | 12.74% |
| 2017-09-30 | $0.86B | $6.65B | 13.72% |
| 2017-06-30 | $0.80B | $6.39B | 13.29% |
| 2017-03-31 | $0.72B | $6.08B | 12.33% |
| 2016-12-31 | $0.56B | $5.91B | 10.00% |
| 2016-09-30 | $0.41B | $5.72B | 8.79% |
| 2016-06-30 | $0.36B | $5.54B | 9.50% |
| 2016-03-31 | $0.28B | $5.31B | 9.63% |
| 2015-12-31 | $0.36B | $2.17B | 17.75% |
| 2015-09-30 | $0.35B | $2.05B | 18.54% |
| 2015-06-30 | $0.34B | $1.94B | 18.99% |
| 2015-03-31 | $0.30B | $1.84B | 17.95% |
| 2014-12-31 | $0.27B | $1.74B | 17.23% |
| 2014-09-30 | $0.22B | $1.64B | 14.99% |
| 2014-06-30 | $0.18B | $1.49B | 13.79% |
| 2014-03-31 | $0.17B | $1.42B | 14.00% |
| 2013-12-31 | $0.16B | $1.24B | 14.46% |
| 2013-09-30 | $0.12B | $1.19B | 11.30% |
| 2013-06-30 | $0.08B | $1.12B | 7.46% |
| 2013-03-31 | $0.00B | $0.99B | 0.10% |
| 2012-12-31 | $0.00B | $0.95B | 0.21% |
| 2012-09-30 | $0.02B | $0.96B | 2.41% |
| 2012-06-30 | $0.05B | $0.95B | 5.10% |
| 2012-03-31 | $0.11B | $0.98B | 12.04% |
| 2011-12-31 | $0.11B | $0.94B | 12.54% |
| 2011-09-30 | $0.11B | $0.90B | 12.46% |
| 2011-06-30 | $0.10B | $0.87B | 12.11% |
| 2011-03-31 | $0.10B | $0.83B | 11.83% |
| 2010-12-31 | $0.10B | $0.80B | 12.14% |
| 2010-09-30 | $0.09B | $0.80B | 12.74% |
| 2010-06-30 | $0.09B | $0.78B | 13.43% |
| 2010-03-31 | $0.09B | $0.75B | 13.98% |
| 2009-12-31 | $0.08B | $0.62B | 14.15% |
| 2009-09-30 | $0.08B | $0.59B | 14.36% |
| 2009-06-30 | $0.08B | $0.59B | 14.57% |
| 2009-03-31 | $0.08B | $0.55B | 15.08% |
| 2008-12-31 | $0.08B | $0.50B | 17.64% |
| 2008-09-30 | $0.06B | $0.48B | 14.03% |
| 2008-06-30 | $0.06B | $0.46B | 14.13% |
| 2008-03-31 | $0.06B | $0.44B | 14.72% |
| 2007-12-31 | $0.07B | $0.42B | 18.43% |
| 2007-09-30 | $0.09B | $0.41B | 23.01% |
| 2007-06-30 | $0.00B | $0.39B | -0.29% |
| 2007-03-31 | $-0.01B | $0.37B | -4.07% |
| 2006-12-31 | $-0.04B | $0.33B | -12.55% |
| 2006-09-30 | $-0.04B | $0.31B | -12.32% |
| 2006-06-30 | $0.04B | $0.37B | 11.24% |
| 2006-03-31 | $0.05B | $0.36B | 14.62% |
| 2005-12-31 | $0.06B | $0.35B | 17.00% |
| 2005-09-30 | $0.05B | $0.33B | 17.48% |
| 2005-06-30 | $0.05B | $0.32B | 18.31% |
| 2005-03-31 | $0.05B | $0.29B | 18.13% |
| 2004-12-31 | $0.04B | $0.27B | 17.56% |
| 2004-09-30 | $0.04B | $0.26B | 17.67% |
| 2004-06-30 | $0.04B | $0.24B | 17.70% |
| 2004-03-31 | $0.04B | $0.23B | 18.97% |
| 2003-12-31 | $0.03B | $0.22B | 20.70% |
| 2003-09-30 | $0.03B | $0.21B | 23.01% |
| 2003-06-30 | $0.03B | $0.12B | 29.18% |
| 2003-03-31 | $0.03B | $0.11B | 28.64% |
| 2002-12-31 | $0.03B | $0.10B | 28.65% |
| 2002-09-30 | $0.02B | $0.10B | 28.30% |
| 2002-06-30 | $0.02B | $0.08B | 31.48% |
| 2002-03-31 | $0.02B | $0.07B | 45.45% |
| 2001-12-31 | $0.01B | $0.06B | 81.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Health Maintenance Organizations | $17.881B | $163.071B |
| Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UnitedHealth Group (UNH) | United States | $291.553B | 15.32 |
| Cigna Group (CI) | United States | $72.033B | 9.49 |
| Humana (HUM) | United States | $28.519B | 12.53 |
| Molina Healthcare (MOH) | United States | $7.455B | 7.45 |
| Select Medical Holdings (SEM) | United States | $1.622B | 11.20 |
| Joint (JYNT) | United States | $0.122B | 0.00 |
| Aethlon Medical (AEMD) | United States | $0.001B | 0.00 |